SmarTrend identified a Downtrend for Myriad Genetics (NASDAQ:MYGN) on February 5th, 2018 at $35.24. In approximately 2 months, Myriad Genetics has returned 17.52% as of today's recent price of $29.07. In the past 52 …
Myriad's stock just completed a long-term bottom in May 2017 ... One of those companies with potential is Myriad Genetics (MYGN). Myriad creates genetic tests to screen for genetic cancer risk and other diseases. It’s currently …
Myriad Genetics, Inc. MYGN was a big mover last session, as its shares rose over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for …
In late January, a Goldman Sachs (GS) analyst expressed concern about the multiple for Myriad Genetics' (MYGN) stock price. “However, we believe the market has priced in the expected stabilization of the Hereditary Cancer Testing …